Efficacy and safety of add-on topiramate vs. metformin on cardiometabolic profile in patients of schizophrenia on atypical antipsychotics with metabolic syndrome: an active-controlled, rater-blinded, parallel-design randomized controlled trial

European Archives of Psychiatry and Clinical Neuroscience · Published 2026-08-04 · DOI 10.1007/s00406-026-02319-6

Authors (7)

Radhika Chakraborty, Debadatta Mohapatra, Tathagata Biswas, Mathan Kumar Ramasubbu, Rituparna Maiti, Archana Mishra, Biswa Ranjan Mishra

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Chakraborty, R., Mohapatra, D., Biswas, T., et al. (2026). Efficacy and safety of add-on topiramate vs. metformin on cardiometabolic profile in patients of schizophrenia on atypical antipsychotics with metabolic syndrome: an active-controlled, rater-blinded, parallel-design randomized controlled trial. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-026-02319-6

Related articles